Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Volpara Health Technologies.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s health powerplays: ‘We’re buying any pullbacks’
Health & Biotech
SomnoMed taps tech for new board hires, posts full-year profit
Experts
Scopo’s powerplays: Strap yourselves in for some M&A
Health & Biotech
Digital health a goldmine for investors
Experts
Scopo’s health powerplays: The cash caboose keeps rolling on
Experts
Scopo’s health powerplays: Markets are getting back to normal
Health & Biotech
The elective surgery stocks getting a boost from the easing of COVID-19 restrictions
News
How have ASX small caps responded to New Zealand’s reopening post-COVID?
Health & Biotech
Dr Boreham’s Crucible: Volpara is all about breasts but in no danger of going bust
Health & Biotech
Volpara makes $$$ in 2019, market shrugs
Experts
ScoPo’s health powerplays: The transition to greatest
Experts
ScoPo’s health powerplays: How to invest in COVID-19
Health & Biotech
ScoPo’s health powerplays: Getting our elective surgery (back) on
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Invion says lasers can trigger anti-cancer immune response in mice
Health & Biotech
Call the midwife: Telehealth has arrived
Health & Biotech
